The landscape of oncology is currently undergoing a paradigm shift as pharmaceutical giants Merck & Co. and biotechnology innovator Moderna…
Read More
Part 1: The Patient Still Needs a CBC: How the CDC Changed the Way We Think About Testing Patients with Ebola and Other Viral Hemorrhagic Fevers
The 2014 West African Ebola epidemic served as a crucible for global healthcare systems, exposing critical vulnerabilities in laboratory biosafety…
Read More
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
The landscape of oncology is undergoing a seismic shift as pharmaceutical giants Merck & Co. and Moderna reach a pivotal…
Read More
Part 1: The Patient Still Needs a CBC: How the CDC Changed the Way We Think About Testing Patients with Ebola and Other Viral Hemorrhagic Fevers
The 2014-2016 West African Ebola epidemic served as a watershed moment for global biosafety, fundamentally altering the operational landscape of…
Read MoreMerck and Moderna’s cancer vaccine is customized for each patient’s tumor
The landscape of oncology is currently undergoing a paradigm shift as pharmaceutical giants Merck & Co. and Moderna advance their…
Read MorePart 1: The Patient Still Needs a CBC: How the CDC Changed the Way We Think About Testing Patients with Ebola and Other Viral Hemorrhagic Fevers
The 2014 West African Ebola epidemic served as a jarring wake-up call for the global healthcare infrastructure, exposing significant vulnerabilities…
Read More
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
The landscape of oncology is currently undergoing a paradigm shift as pharmaceutical giants Merck & Co. and Moderna move toward…
Read More
Part 1: The Patient Still Needs a CBC: How the CDC Changed the Way We Think About Testing Patients with Ebola and Other Viral Hemorrhagic Fevers
The 2014 West African Ebola epidemic served as a crucible for global healthcare systems, exposing significant fractures in laboratory biosafety…
Read More
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
The landscape of oncology is currently undergoing a paradigm shift as pharmaceutical giants Merck & Co. and Moderna transition from…
Read More
Part 1: The Patient Still Needs a CBC: How the CDC Changed the Way We Think About Testing Patients with Ebola and Other Viral Hemorrhagic Fevers
The 2014 West African Ebola epidemic served as a crucible for global public health, fundamentally altering the trajectory of laboratory…
Read More
